[1] |
任淑萍.小牛血清去蛋白注射液与小牛血去蛋白注射液有效成分含量和生物活性的比较[M].中华神经医学杂志, 2006, 5(8): 767-769.
|
[2] |
吕媛,权菊香.小牛血清去蛋白注射液对脑细胞缺血缺氧的保护作用及临床应用[M].中国临床药理学杂志, 2006, 22(2): 141-144.
|
[3] |
江基尧,朱诚.颅脑创伤临床救治指南[M].上海:第二军医大学出版社, 2002.
|
[4] |
de Groot H, Bercht M, Machicao F. Evidence for a factor protective against hypoxic liver parenchymal cell injury in a protein-free blood extrat[M]. Res Commun Chem Pathol Pharmacol, 1990, 68(1):125-128
|
[5] |
Kuninaka T, Senga Y, Senge H, et al. Nature of enhanced mitochondrial oxidative metabolism by a calf blood extract[M]. J Cell Physiol, 1991, 146(1): 148-155.
|
[6] |
Mychka VB, Chazova IE, Gornostaev VV, et al. Primary prophylaxis of cerebrovascular complications in patients with metabolic syndrome[M]. Ter Arkh, 2005, 77(10): 20-24.
|
[7] |
杨芳,邓杰.早期乳酸清除率对急性重型颅脑损伤的预后判断价值[M].浙江临床医学, 2016, 18(3): 448-450.
|
[8] |
赵飞,沈婷,章卫桥.早期乳酸清除率评估重型颅脑创伤合并高乳酸血症患者预后的研究[M].浙江创伤外科, 2013, 18(1): 14-15.
|
[9] |
李朝阳,李春花,孙浩,等.儿童癫痫持续状态的临床分析及脑脊液乳酸变化[M].中西医结合心脑血管病杂志, 2015, 13(15): 1709-1711.
|
[10] |
Okorie ON, Dellinger P. Lactate: biomarker and potential therapeutic target[M]. Crit Care Clin, 2011, 27(2): 299-326.
|
[11] |
Nguyen HB, Ricers EP, Knoblich BP, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock[M]. Crit Care Med, 2004, 32(8): 1637-1642.
|
[12] |
Stein M, Schomacher J, Scharbrodt W, et al. Cerebrospinal fluid lactate concentration after withdrawal of metabolic suppressive therapy in subarachnoid hemorrhage[M]. Acta Neurochir Suppl, 2012, 114: 333-337.
|
[13] |
Arnold RC, Shapiro NI, Jones AE, et al. Multicenter stude of early lactate clearance as a determinant of survival in patients with presumed sepsis[M]. Shock, 2009, 32(1): 35-39.
|
[14] |
张永明,漆松涛,方陆雄,等.急性重型颅脑损伤后全身炎症反应综合征的临床研究[M].中国临床神经外科杂志, 2006, 11(6): 344-345.
|
[15] |
袁紫刚,金国良,张建民.血乳酸水平在颅脑外伤合并全身性炎症反应综合征中的死亡预测分析[M].中华急诊医学杂志, 2011, 20(9): 992-994.
|